Revised SPC: Trelegy Ellipta 92 micrograms/55 micrograms/22 micrograms (fluticasone furoate/umeclidinium bromide/vilanterol trifenatate) inhalation powder, pre-dispensed

SPC updated with adverse reactions of hypersensitivity reactions, including anaphylaxis, angioedema, urticaria, and rash.

Source:

electronic Medicines compendium